These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4994614)

  • 21. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia.
    Girelli G; Arcese W; Bianchi A; Mauro FR; Malagnino F; Adorno G; Iurlo A; Perrone MP; Papa G
    Haematologica; 1986; 71(1):46-9. PubMed ID: 3084356
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS; Storb R; Weiden PL; Thomas ED
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.
    Santos GW; Sensenbrenner LL; Anderson PN; Burke PJ; Klein DL; Slavin RE; Schacter B; Borgaonkar DS
    Transplant Proc; 1976 Dec; 8(4):607-10. PubMed ID: 11591
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of acute leukosis in children with arabinosyl cytosine].
    Plüss HJ; Hitzig WH
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1783-4. PubMed ID: 5291102
    [No Abstract]   [Full Text] [Related]  

  • 25. The cost of marrow transplantation compared with the cost of conventional treatment for acute leukaemia and aplastic anaemia.
    Rollinson DH
    N Z Med J; 1982 May; 95(707):310-1. PubMed ID: 7048161
    [No Abstract]   [Full Text] [Related]  

  • 26. Autologous bone marrow transplantation in relapsed acute leukemias and chronic myeloid leukemia in blast crisis.
    Izzi T; Moretti L; Polchi P; Galimberti M; Delfini C; Porcellini A; Lucarelli G
    Haematologica; 1983; 68(3):368-80. PubMed ID: 6411531
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transplant of autologous bone marrow: indications and results].
    Bernasconi C; Alessandrino P
    Riv Emoter Immunoematol; 1985; 32(1):1-16. PubMed ID: 3909360
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical aspects of Rh incompatibility. I. Transient disorders of erythropoiesis as a result of persistent Rh-antibodies after exchange transfusion].
    Reitzig C; Gmyrek D; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1971 Mar; 26(11):497-503. PubMed ID: 4995286
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.
    Lozano M; Cid J
    Transfus Med Rev; 2003 Jan; 17(1):57-68. PubMed ID: 12522772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibilities and results of the use of a cell separator in hematology].
    Stacher VA; HOCKER P; Pittermann E
    Wien Med Wochenschr; 1975 Jan; 125(1-3):35-44. PubMed ID: 236623
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytology of experimental inflammations in childhood leukemia].
    Bílek O; Jansa P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(4):414-8. PubMed ID: 4195489
    [No Abstract]   [Full Text] [Related]  

  • 33. Red blood cell survival evaluated by RhD-negative cells transfused into RhD-positive patients.
    Onozaki F; Kishino K; Muroi K
    Transfus Apher Sci; 2015 Jun; 52(3):317-8. PubMed ID: 25634789
    [No Abstract]   [Full Text] [Related]  

  • 34. [Implantation of fetal thymus tissue in patients with progressive malignant neoplasms (author's transl)].
    Mertelsmann R; Koch G; Schumpelick V; Tachezy H
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2063-6. PubMed ID: 4216812
    [No Abstract]   [Full Text] [Related]  

  • 35. [Transfusion of blood incompatible with Rh factor: evolution and use of immunoglobulin anti-D].
    Almuna R; Testa E; Zeldis S; Monterríos E
    Rev Chil Obstet Ginecol; 1976; 41(5):267-73. PubMed ID: 829550
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplantation.
    Ramsay NK
    Trans Assoc Life Insur Med Dir Am; 1988; 71():162-73. PubMed ID: 3285567
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants.
    Trigg ME; Billing R; Sondel PM; Exten R; Hong R; Bozdech MJ; Horowitz SD; Finlay JL; Moen R; Longo W
    Cancer Treat Rep; 1985 Apr; 69(4):377-86. PubMed ID: 3888387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White blood cell transfusions.
    Schwarzenberg L; Mathé G; de Grouchy J; de Nava C; de Vries MJ; Amiel JL; Cattan A; Schneider M; Schlumberger JR
    Isr J Med Sci; 1965 Sep; 1(5):925-56. PubMed ID: 5867749
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: "minitransplant"].
    Gómez-Almaguer D; Ruiz-Argüelles GJ; González-Llano O; Ruiz-Argüelles A; Cantú-Rodríguez OG
    Gac Med Mex; 2002; 138(3):235-9. PubMed ID: 12096391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.